- Immuneering Announces Closing of its Upsized Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
- AXIM® Biotechnologies to Acquire Technology Including Two FDA-Cleared 510(k)’s for Diagnostic Testing of Dry Eye Disease
- Yield10 Bioscience to Announce Second Quarter 2021 Financial Results and Host a Conference Call on Wednesday, August 11, 2021
- Xeriant Announces Uplisting to OTCQB Venture Market
- Arbutus to Present at Wedbush PacGrow Healthcare Virtual Conference
- Global Meibomian Gland Dysfunction Treatment Market Size to Grow at a CAGR of 9.2% from 2021 to 2030
- Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2021 Financial Results
- Recro To Report Financial Results for Second Quarter 2021 on August 9, 2021
- Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Myriad Genetics Expands Access to Genetic Testing with Launch of First Polygenic Breast Cancer Risk Assessment Score Validated for Women of All Ancestries
